SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining Inc. is a key discussion point following its strategic $7 billion acquisition of New Gold, positioning it as a major North American precious metals producer amidst a strong bull market for gold and silver. The community is actively discussing CDE's robust Q3 earnings and silver's record highs, with many anticipating significant upside as institutional interest grows in the mining sector.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is drawing significant attention following positive clinical data for Tradipitant in addressing GLP-1 induced nausea and vomiting, coupled with multiple near-term regulatory decisions for its pipeline. The community is vigorously debating the stock's undervaluation and considerable growth potential from these catalysts, particularly Tradipitant's role in the expanding GLP-1 market.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending after its experimental depression treatment, BHV-7000, failed to meet its primary endpoint in a Phase 2 study, leading the company to halt further psychiatric trials for the drug. Despite the setback, which analysts widely deemed "disappointing but not surprising," community focus is now strongly shifting to the company's broader pipeline, especially upcoming pivotal data for its epilepsy program and other key immunology and obesity assets.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs and escalating industrial demand from AI data centers, EV batteries, and solar power. This rally is significantly fueled by tightening global physical supply, exacerbated by upcoming export restrictions from key producing nations. The community is actively discussing a potential "silver squeeze" and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly is trending due to a confluence of positive developments, including recent international military orders for its Commander 3XL and successful demonstrations of its Outrider drone for U.S. border security. The community is actively discussing Draganfly's strategic position as an undervalued, NDAA-compliant pure-play, poised to capitalize on the rapidly expanding drone sector driven by increasing military and commercial demand, especially as the U.S. military eyes a massive ramp-up in drone acquisitions.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is facing intense scrutiny and widespread community backlash following a massive data breach affecting millions of users, with discussions heavily focused on the company's response and its CEO's perceived lack of accountability in South Korea. This has triggered calls for boycotts and potential multi-billion dollar lawsuits, even as some investors eye the stock as an oversold opportunity, weighing its market dominance against significant regulatory and consumer trust challenges.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro is trending due to rapidly escalating geopolitical tensions in the Middle East, which are propelling oil prices higher and intensifying market interest in energy producers. The community is actively discussing PBR's unique position as an undervalued oil major operating in a non-conflict region, prompting expectations for strong performance and continued attractive dividends.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines, Inc. is trending amid anticipation of an impending FCC ban on Chinese drone components, which is expected to create a significant demand for its U.S.-made, NDAA-compliant parts. The community is buzzing about the company's strategic positioning to capture a large share of the rapidly expanding domestic drone market, further fueled by recent multi-million dollar purchase orders and its reported profitability. This focus on American-made drone technology, supported by major defense spending initiatives, positions UMAC as a key player in the unfolding "Drone Dominance" narrative.

TOSHI

TOSHI is seeing significant community discussion and increased volume, driven by its recent Coinone KRW listing and its positioning as the "Face of Base" coin. Enthusiasts are actively accumulating, believing it's currently oversold and poised for a future rally due to its growing utility and strong ecosystem presence.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver ($ZSL) is trending as the community hotly debates the sustainability of silver's recent rally, with many anticipating a significant pullback for the metal. Traders are actively initiating or adding to short positions, betting that silver is overbought and due for a correction, citing the historical tendency of parabolic moves to reverse. However, some caution against shorting precious metals in the current macro environment, highlighting the inherent risks and historical underperformance of inverse leveraged ETFs over time.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX no, his shares converted a long time a into nantcell. I also don’t think he got any additional cvr shares since milestones were not met on time. The fool recently lost a significant arbitration hearing with his new startup co $HCWB to immunitybio with it’s anktiva clone, rendering hcwb virtually worthless orger than a daytrading vehicle.

Tino McGillicuty

John Mack

cyberInvest

$IBRX has anyone consider Ting Wong the original founder of Altor which Immunity bought has option either $160 mil in cash or shares. Maybe some entity use this to short knowing that $160 mil can convert into shares

StockTwits for iOS

ImmunityBio Inc

John

StockTwits Web

HCW Biologics Inc

 no, his shares converted a long time a into nantcell. I also don’t think he got any additional cvr shares since milestones were not met on time. The fool recently lost a significant arbitration hearing with his new startup co 

 to immunitybio with it’s anktiva clone, rendering hcwb virtually worthless orger than a daytrading vehicle.

BUY N HOLD IS DEAD

Hing c wang aha $HCWB also have up all ip to ibrx .  
The parties reached a settlement agreement in July 2024, the details of which were confidential. However, public SEC filings indicate that the settlement involved:  
No monetary exchange from ImmunityBio. 
HCW Biologics and Dr. Wong transferring and assigning specific intellectual property (including patents, pending patent applications, and know-how) and drug candidates to ImmunityBio. 
ImmunityBio receiving rights to several molecules developed using HCW Biologics&#39; platform, including HCW9218, HCW9219, HCW9209, and their derivatives.  
While the exact &quot;loss&quot; amount isn&#39;t publicly stated due to the confidential nature of the settlement, the outcome resulted in Dr. Wong&#39;s company giving up key IP and drug candidates to ImmunityBio without receiving any money, effectively resolving the claims in ImmunityBio&#39;s favor with respect to the ownership of the disputed assets. All parties agreed to cover their own legal expenses.

Petey99

 also have up all ip to ibrx .  
The parties reached a settlement agreement in July 2024, the details of which were confidential. However, public SEC filings indicate that the settlement involved:  
No monetary exchange from ImmunityBio. 
HCW Biologics and Dr. Wong transferring and assigning specific intellectual property (including patents, pending patent applications, and know-how) and drug candidates to ImmunityBio. 
ImmunityBio receiving rights to several molecules developed using HCW Biologics' platform, including HCW9218, HCW9219, HCW9209, and their derivatives.  
While the exact "loss" amount isn't publicly stated due to the confidential nature of the settlement, the outcome resulted in Dr. Wong's company giving up key IP and drug candidates to ImmunityBio without receiving any money, effectively resolving the claims in ImmunityBio's favor with respect to the ownership of the disputed assets. All parties agreed to cover their own legal expenses.

@Diefreeandsell 
I just look up 10k filing they have until Dec 2026 either received cash or shares

 
I just look up 10k filing they have until Dec 2026 either received cash or shares

@Johnluck so you think ibrx exceeds 1 billion in anktiva sales by Dec 2026? I don’t see it, maybe come close to half that.

 so you think ibrx exceeds 1 billion in anktiva sales by Dec 2026? I don’t see it, maybe come close to half that.

@Diefreeandsell you are right I don’t think they can achieve 1 billion dollars in revenue by the end of next year

 you are right I don’t think they can achieve 1 billion dollars in revenue by the end of next year

@Johnluck and wong as well as pss don’t get any additional stock.

 and wong as well as pss don’t get any additional stock.